[6-K] Nutrien Ltd. Current Report (Foreign Issuer)
Rhea-AI Filing Summary
Nutrien Ltd. plans a renewed share repurchase program under a normal course issuer bid, allowing it to buy back up to 24,057,066 common shares, or five percent of its 481,141,322 shares outstanding as of February 17, 2026. Purchases may occur on the TSX, NYSE or other permitted trading systems between March 3, 2026 and the earlier of March 2, 2027 or completion of the program, and repurchased shares will be cancelled. Daily TSX purchases are generally capped at 430,107 shares, reflecting 25 percent of recent average daily volume. Under its prior program, Nutrien had already repurchased 8,708,901 shares at a weighted-average price of US$58.56, for a total of US$510,031,461, through open market purchases.
Positive
- None.
Negative
- None.
Insights
Nutrien renews authority to repurchase up to 5% of its shares.
Nutrien obtained TSX approval for a normal course issuer bid covering up to 24,057,066 common shares, equal to five percent of the 481,141,322 shares outstanding as of February 17, 2026. Any shares bought will be cancelled, reducing share count.
The company can repurchase through the TSX, NYSE and other systems, subject to limits such as a 430,107-share daily cap on the TSX based on recent trading volumes. An automatic purchase plan allows buying during blackout periods, with management discretion outside those periods.
Under the prior bid expiring on March 2, 2026, Nutrien had already bought 8,708,901 shares at a weighted-average price of US$58.56, totaling US$510,031,461. Actual impact will depend on how much of the new 5 percent capacity the company ultimately uses.
AI-generated analysis. How Rhea-AI works. Not financial advice.